Table 2 Recently delivered women: Receipt and use of misoprostol for PPH prevention: % (n)
From: Postpartum hemorrhage prevention in Nepal: a program assessment
Mountain region | Hill region | Terai region | P-valuea | |
(n = 690) | (n = 690) | (n = 690) | ||
Received information during pregnancy | 9.7 (67) | 19.3 (133) | 15.2 (105) | <0.001 |
Received misoprostol during pregnancy | 7.5 (52) | 17.3 (119) | 12.9 (89) | <0.001 |
Among those who received misoprostol | n = 52 | n = 119 | n = 89 | |
Source of misoprostol | 0.005 | |||
FCHV | 80.8 (42) | 78.2 (93) | 94.4 (84) | |
Health facility provider | 17.3 (9) | 21.0 (25) | 5.6 (5) | |
Friend/family | 1.9 (1) | 0.8 (1) | 0.0 (0) | |
Used misoprostol for PPH prevention | 48.1 (25) | 45.4 (54) | 31.5 (28) | 0.069 |
Among those who used misoprostol | n = 25 | n = 54 | n = 28 | |
Used all 3 tablets | 84.0 (21) | 90.7 (49) | 92.9 (26) | 0.641 |
Used immediately after delivery of baby | 80.0 (20) | 75.9 (41) | 64.3 (18) | 0.391 |
Used misoprostol correctlyb | 68.0 (17) | 72.2 (39) | 64.3 (18) | 0.764 |
Would recommend miso to others (n = 98) | 100.0 (25) | 100.0 (47) | 96.2 (25) | 0.520 |